Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Sublingual Microcirculatory Imaging As a Novel Tool to Monitor for Cytokine Release Syndrome after Chimeric Antigen Receptor T-Cell Therapy

Andrew Deitchman, MD, Michael McCurdy, MD, Muhammad Gilani, MBBS, Aaron P. Rapoport, MD, Kathleen Ruehle, RN, Nancy M. Hardy, MD, Elizabeth Hutnick, RN, Jean Yared, MD, Saurabh Dahiya, MD

Blood (2018) 132 (Supplement 1): 5408.

https://doi.org/10.1182/blood-2018-99-115393

Published: 2018

Journal Articles

Outcomes of Hospitalization for Stem Cell Transplant in Sickle Cell Disease: Are We There Yet?

Amandeep Godara, MD, Nauman Siddiqui, MD, Amber Afzal, MD, Marina Khan, MD, Jean Yared, MD, Ankit Kansagra, MD, Saurabh Dahiya, MD

Blood (2018) 132 (Supplement 1): 4640.

https://doi.org/10.1182/blood-2018-99-113908

Published: 2018

Journal Articles

Blood and Blues: Prevalence of Mental Health Disorders in Patients Hospitalized with Acute Leukemia

Amandeep Godara, MD, Nauman Siddiqui, MD, Zarmina Khan, DMD, Ankit Kansagra, MD, Jean Yared, MD, Saurabh Dahiya, MD

Blood (2018) 132 (Supplement 1): 4871.

https://doi.org/10.1182/blood-2018-99-120239

Published: 2018

Journal Articles

Similar Survival for African American and Caucasian Multiple Myeloma Patients Receiving Auto-SCT

Cameron Dell, BS, Olga Goloubeva, PhD MSc, Aaron P. Rapoport, MD, Mehmet H. Kocoglu, MD, Nancy M. Hardy, MD, Jean Yared, MD, Ning Ma, CRNP, Ashraf Z. Badros, MD

Blood (2017) 130 (Supplement 1): 2177.

https://doi.org/10.1182/blood.V130.Suppl_1.2177.2177

Published: 2017

Journal Articles

Plasma Cell Leukemia (PCL): Clinical Characteristics, Outcomes, and the Impact of Circulating Plasma Cells (CPC) Percentage — A Single Center Experience

Noa G. Holtzman, MD, Olga Goloubeva, PhD MSc, Zeba Singh, MBBS, Sameer Sawhney, MD, Ying Zou, MD PhD, Jean Yared, MD, Nancy M. Hardy, MD, Aaron P. Rapoport, MD, Mehmet H. Kocoglu, MD, Ashraf Z. Badros, MD

Blood (2017) 130 (Supplement 1): 3035.

https://doi.org/10.1182/blood.V130.Suppl_1.3035.3035

Published: 2017

Journal Articles

Patterns and Determinants of Cancer-Directed Drug Therapy in Medicare Beneficiaries with Multiple Myeloma

Julia F Slejko, PhD, Dorothy Romanus, RPh, MSc, PhD, Daisuke Goto, PhD, Eberechukwu Onukwugha, PhD, Rahul Khairnar, MS, Brian Seal, RPh, MBA, PhD, Candice Yong, PhD, Jean Yared, MD

Blood (2016) 128 (22): 5926.

https://doi.org/10.1182/blood.V128.22.5926.5926

Published: 2016

Journal Articles

Determinants of Receipt of Stem Cell Transplant in Elderly Medicare Beneficiaries with Multiple Myeloma

Jean Yared, MD, Daisuke Goto, PhD, Eberechukwu Onukwugha, PhD, Rahul Khairnar, MS, Brian Seal, RPh, MBA, PhD, Dorothy Romanus, RPh, MSc, PhD, Candice Yong, PhD, Julia F Slejko, PhD

Blood (2016) 128 (22): 5927.

https://doi.org/10.1182/blood.V128.22.5927.5927

Published: 2016

Journal Articles

Outcome Comparison of Lymphoma and Myeloma Patients after Autologous Stem Cell Transplantation (ASCT) with Peripheral Blood Stem Cell Mobilization Between Plerixafor (P) Mobilized in Poor Mobilizer Patients and Non-Plerixafor Mobilized Patients

Shahbaz A. Malik, MD, Saul Yanovich, MD, Aaron P. Rapoport, MD, Ashraf Z Badros, MD, Nancy M. Hardy, MD, Mehmet H. Kocoglu, MD, Alison Duffy, Kathleen Ruehle, Jennifer Nishioka, Olga Goloubeva, PhD, Jean Yared, MD

Blood (2015) 126 (23): 5507.

https://doi.org/10.1182/blood.V126.23.5507.5507

Published: 2015

Journal Articles

Racial Differences in Molecular Cytogenetic Abnormalities in Black and White Patients with Multiple Myeloma (MM): A Single-Center Experience

Ying S Zou, MD PhD, Yi Huang, PhD, Zhou Feng, Sin Chan, Shweta Shukla, Ina Lee, MDPhD, Zeba Singh, MD, Mehmet H. Kocoglu, MD, Aaron P. Rapoport, MD, Ning Ma, Nancy M. Hardy, MD, Jean Yared, MD, Maria R Baer, MD, Ashraf Z Badros, MD

Blood (2015) 126 (23): 1767.

https://doi.org/10.1182/blood.V126.23.1767.1767

Published: 2015

Journal Articles

A Phase II Study of Anti PD-1 Antibody Pembrolizumab, Pomalidomide and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

Ashraf Z. Badros, MD, Mehmet H. Kocoglu, MD, Ning Ma, NP, Aaron P. Rapoport, MD, Emily Lederer, RN, Sunita Philip, MBBS, Patricia Lesho, Cameron Dell, Nancy M. Hardy, MD, Jean Yared, MD, Olga Goloubeva, PhD, Zeba Singh, MD

Blood (2015) 126 (23): 506.

https://doi.org/10.1182/blood.V126.23.506.506

Published: 2015

NARROW

Sublingual Microcirculatory Imaging As a Novel Tool to Monitor for Cytokine Release Syndrome after Chimeric Antigen Receptor T-Cell Therapy

Outcomes of Hospitalization for Stem Cell Transplant in Sickle Cell Disease: Are We There Yet?

Blood and Blues: Prevalence of Mental Health Disorders in Patients Hospitalized with Acute Leukemia

Similar Survival for African American and Caucasian Multiple Myeloma Patients Receiving Auto-SCT

Plasma Cell Leukemia (PCL): Clinical Characteristics, Outcomes, and the Impact of Circulating Plasma Cells (CPC) Percentage — A Single Center Experience

Patterns and Determinants of Cancer-Directed Drug Therapy in Medicare Beneficiaries with Multiple Myeloma

Determinants of Receipt of Stem Cell Transplant in Elderly Medicare Beneficiaries with Multiple Myeloma

Outcome Comparison of Lymphoma and Myeloma Patients after Autologous Stem Cell Transplantation (ASCT) with Peripheral Blood Stem Cell Mobilization Between Plerixafor (P) Mobilized in Poor Mobilizer Patients and Non-Plerixafor Mobilized Patients

Racial Differences in Molecular Cytogenetic Abnormalities in Black and White Patients with Multiple Myeloma (MM): A Single-Center Experience

A Phase II Study of Anti PD-1 Antibody Pembrolizumab, Pomalidomide and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only